Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release (ER) Capsules, 2 mg and 4 mg.

Mylan N.V. MYL disclosed the launch of Temozolomide Capsules, 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg, which is a generic version of Merck's Temodar, in the United States. According to the ...

Mylan N.V. (NASDAQ: MYL ) revealed Friday the launch of Dutasteride Capsules, 0.5 mg, the generic version of GlaxoSmithKline's Avodart Capsules in the United States. The company got the ultimate ...

Mylan announced the launch of Bexarotene capsules, the generic version of Valeant’s Targretin Capsules.. Targretin is a retinoid indicated for the treatment of cutaneous manifestations of ...

The FDA approved Mylan’s tamsulosin hydrochloride capsules in the 0.4 mg strength, and Mylan has launched the drug. The drug is a generic version of Boehringer Ingelheim’s benign prostatic ...

Mylan announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for Fenofibrate Capsules, the generic of Lupin's Antara. Menu SECTIONS. ... (800) RX-MYLAN or visit www.mylan.com.

Fluoxetine Capsules are the generic version of Eli Lilly and Company's Prozac(R) Capsules. Fluoxetine Capsules had U.S. sales of approximately $118 million for the 12 months ending March 31, 2007 ...

PITTSBURGH, May 23, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Divalproex Sodium Capsules USP, 125 mg, the generic ...

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories.

Mylan N.V. (NASDAQ: MYL ) disclosed the launch of Temozolomide Capsules, 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg, which is a generic version of Merck's Temodar, in the United States.